Active Pharmaceutical Ingredients (APIs)

AMRI Promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

Orphan Drugs

Europe Oil Refining Margins to Return to Reality in 2013

SAFC, CrystalGenomics Sign Collaboration Agreement

Almac Concludes Commercial API Manufacturing Facility Expansion Plans

AMRI, Shire Extend API Supply Agreement

Dr. Reddy's CPS Business Expands Manufacturing Operations in Mirfield, UK

Manufacturing of HPAPIs and ADC Toxins for the Drugs of Tomorrow

Expect More

The Future of Fine Chemical Production

Neuland Labs Reports Q1 2013 Financial Results

FDA Reform Act Signed into Law

Neuland Labs Reports Financial Results for Fiscal Year 2012

7 Steps to GMP Compliance

Innovation Expected from API Manufacturers

APIs in China

Saltigo at the BOS Forum

API Development - Changing demands and requirements in the design and implementation of work programs associated with both non-clinical and clinical phase development of novel APIs is one of the key topics to be covered in the BOS Forum on Sept. 20 at the Royal College of Physicians in London.

Chemical Distribution: Three Attractive Markets

Johnson Matthey Q1 Underlying Profit Rises; Sees Strong Growth In H1

Mark C. Griffiths Named Carbogen Amcis CEO

Flow Chemistry for Hazardous Reactions

Fine Chemicals: The Top 10

How Solvias Relocated to a New Location without Missing a Beat

The EFCG is Pushing Its Agenda Forward During Complex Times

EFCG and APIC Welcome Adoption of New Falsified Medicines Directive

Carbogen Amcis Announces Plan to Restructure

Novasep, instrAction Expand Alliance to Include Taxane Purification

Carbogen Amcis Enhances Stability Studies Capacity

Pharma Sourcing from India and China

DSM and Codexis Sign Enzyme Supply Agreement

Expect High Performance

Here, There, Everywhere

Filtration, Simplified

Ubichem Approved for cGMP Radiolabelled API Production

Turning Point